TRPV1 and migraine disorder: TRPV1 activity is further modulated by inflammatory mediators, such as prostaglandin E2 and bradykinin, which trigger the release of pro-inflammatory and pro-migraine neuropeptides, including CGRP and SP, within the meninges [90,91].